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Antibody responses to viral infections are sus-
tained for decades by long-lived plasma cells
(LLPCs). However, LLPCs have yet to be charac-
terized in humans. Here we used CD19, CD38,
and CD138 to identify four PC subsets in
human bone marrow (BM). We found that the
CD19CD38hiCD138+ subset was morphologically
distinct, differentially expressed PC-associated
genes, and exclusively contained PCs specific for
viral antigens to which the subjects had not
been exposed for more than 40 years. Protein se-
quences of measles- and mumps-specific circu-
lating antibodies were encoded for by CD19
CD38hiCD138+ PCs in the BM. Finally, we found
that CD19CD38hiCD138+ PCs had a distinct RNA
transcriptome signature and human immunoglob-
ulin heavy chain (VH) repertoire that was relatively
uncoupled from other BM PC subsets and prob-
ably represents the B cell response’s ‘‘historical
record’’ of antigenic exposure. Thus, our studies
define human LLPCs and provide a mechanism
for the life-long maintenance of anti-viral anti-
bodies in the serum.132 Immunity 43, 132–145, July 21, 2015 ª2015 Elsevier Inc.INTRODUCTION
Circulating high-affinity antibodies provide protection against
previously encountered pathogens. This serological memory is
maintained for decades by long-lived plasma cells (LLPCs)
without re-exposure to antigen (Amanna et al., 2007; Fairfax
et al., 2008; Oracki et al., 2010). In mice, virus-specific LLPCs
survive in the bonemarrow (BM) and secrete antibody for essen-
tially the animal’s lifespan (Manz et al., 1997; Slifka and Ahmed,
1998). These LLPCs are maintained in the absence of memory B
cells (Ahuja et al., 2008; Slifka and Ahmed, 1998), suggesting that
they are truly long-lived, rather than being replenished from
memory precursors.
BM-resident LLPCs are also thought to be the main source
of circulating IgG antibody in humans (McMillan et al., 1972).
The striking longevity of at least some human PCs is best illus-
trated by the life-long persistence of serum antibodies gener-
ated in response to natural infection by measles and mumps
viruses, whose half-life has been estimated at 3,014 and 542
years, respectively (Amanna et al., 2007). In contrast, serum
antibody responses against tetanus vaccination have a half-
life of 11 years and responses to influenza viruses are variable
depending on whether exposure was by immunization or in-
fection (Amanna et al., 2007). Such a wide range is consistent
with differential participation of bona fide LLPCs in different
immune responses, a proposition also supported by the differ-
ential stability of diverse autoantibody responses and their
variable susceptibility to B cell depletion therapy (Cambridge
et al., 2006).
The expression of markers commonly used to define LLPCs is
heterogeneous and not limited to BM PCs. Although CD138 is
expressed by BM PCs (Medina et al., 2002), its expression can
also be induced on PCs in short-term cultures (Huggins et al.,
2007; Jourdan et al., 2011) and approximately half of the circu-
lating PCs generated during an acute immune response also ex-
press CD138 (Gonza´lez-Garcı´a et al., 2006; Medina et al., 2002;
Qian et al., 2010), even thoughmost of these cells are short lived.
In turn, CD138-expressing PCs in the BM are heterogeneous in
their expression of various markers, including CD19 and HLA-
DR (Liu et al., 2012; Medina et al., 2002). Moreover, receptors
important for PC homing and survival, such as CXCR4 and
BCMA, also fail to distinguish between long-lived and short-lived
PCs (Benson et al., 2008; Medina et al., 2002). Thus, the pheno-
type of human LLPCs remains undefined, and as a result, these
cells have not been rigorously characterized.
Here we tested whether LLPCs could be definitively distin-
guished from other PCs in human BM. We found that PCs spe-
cific for viruses encountered more than 40 years prior to the
study were exclusively contained within the CD19CD38hi
CD138+ subset. These cells have a distinct PC morphology,
are predominantly non-cycling, and express many of the gene
products implicated in LLPC function, homing, and survival.
We also show that the CD19CD138+CD38+ cells in the BM
are the only ones to encode circulating serum antibodies specific
for measles and mumps and that monoclonal antibodies recon-
structed from these sequences exclusively bind to the appro-
priate antigens. Finally, we show that the CD19CD138+CD38+
subset of BM PCs has a distinct RNA transcriptome signature
and a broadly diverse VH repertoire that is not dominated by
large, clonally related populations and contains sequences that
are mostly unrelated to those in other PC populations in the
BM, suggesting that these cells probably represent the historical
record of antigenic exposure.
RESULTS
Characterization of Distinct PCSubsets in HumanBMby
Frequency, Ig Secretion, Morphology, and Isotypes
To understand PC heterogeneity in the human BM, iliac crest as-
pirates were obtained from 14 healthy adults without a history of
infection or vaccination within the previous month and cell sus-
pensions were analyzed by flow cytometry. We initially gated
on live lymphocytes lacking CD3 or CD14 expression (non-T
cells, non-monocytes) or IgD-negative cells (to eliminate late
transitional and naive B cells) (Figure 1A). The remaining cells
were divided into CD19+ and CD19 populations and subse-
quently characterized by the expression of CD138 and CD38
(Figure 1A) as previously described (Liu et al., 2012; Medina
et al., 2002; Mei et al., 2015; Rawstron et al., 2002). Because
all PCs in human BM express high amounts of CD38 (Rawstron
et al., 2002), we confined our subsequent analysis to four popu-
lations: CD19+CD38hiCD138 cells (subset A), CD19+CD38hi
CD138+ cells (subset B), CD19CD38hiCD138 cells (subset
C), and CD19CD38hiCD138+ cells (subset D) (Figure 1A). The
frequencies of all the PC subsets were validated with the use
of two separate anti-CD19 monoclonal antibodies (SJ25C1and HIB19 clones) and alternative gating strategies (Figure S1).
The frequencies of each of the four populations varied between
individuals (Figure 1B), but subset B was generally the largest
and subset C was generally the smallest. The mean yields for
subsets A, B, C, and D were 3,666 ± 4,589; 4,785 ± 7,307;
1,910 ± 2,767; and 2,848 ± 4,050 cells/ml, respectively. The
average percentages of BM mononuclear cells for subsets A,
B, C, and D were 0.05 ± 0.02, 0.07 ± 0.06, 0.02 ± 0.02, and
0.04 ± 0.02, respectively.
To enumerate functional PCs within each subset, we per-
formed IgG and IgA ELISPOTs. In contrast to naive B cells
(CD19+IgD+CD27), all PC subsets contained IgG- and IgA-
secreting cells (Figure 1C). The frequency of IgG-secreting cells
was highest in subset D and lowest in subset C (Figure 1D),
whereas the frequency of IgA-secreting cells was higher in sub-
sets A and B than in subsets C and D (Figure 1D). Only in subset
D was the ratio of IgG:IgA significantly different (p = 0.03, N = 6).
The combined frequencies of IgG- and IgA-secreting cells made
up about 20%–35% of the input population in the ELISPOT as-
says (Figure 1D). The low frequency of ELISPOTs is most likely
due to reduced viability or functionality of sorted PCs, because
control studies showed that only 24% of IgG-secreting cells in
total PBMCs were recovered after the sorting process (data
not shown). In addition, contamination with non-PCs was less
likely because post-sort purity was 92%–95%.Moreover, similar
frequencies of ELISPOTs (19%–45% of input cells) were ob-
tained from sorted multiple myeloma cell lines. Thus, the rela-
tively low frequencies of ELISPOTs in our sorted subsets are
likely explained by reduced viability or function and not by
contamination with other cell types.
Given that PCs display characteristic morphological features,
such as an eccentric oval nucleus and a prominent Golgi appa-
ratus (Miller, 1931), we performed cytospins of cells from each
subset, stained them with Wright-Giemsa, and examined 100
cells in each fraction by microscopy. Cells in each subset had
distinctive features of PCs (Figure 1E). However, cells from sub-
set D displayed unique features including a more condensed
nucleus and a higher cytoplasm/nucleus ratio (Figure 1E). In
addition, cells in subset D had the most homogeneous features,
with consistently well-rounded nuclei and distinct Golgi. These
distinct features were observed in cells from three separate pa-
tients (ages 40, 55, and 60 years). Lastly, a large majority (74%)
of cells in subset D prominently displayed large vacuoles, a
feature rarely observed (<1% of cells) in other subsets, including
the other CD138+ cells of subset B (Figure 1E). We also readily
identified PCs with and without vacuoles (subsets D and B) in
Wright-Giemsa-stained BM aspirates from healthy patients (Fig-
ure S2), suggesting that vacuoles are not artifacts of FACS sort-
ing. Finally, none of our donors demonstrated any signs of malig-
nancy for up to 2 years after analysis. Thus, we conclude that
cytoplasmic vacuoles are a physiological feature of healthy
PCs and are restricted to cells within subset D.
We next determined the relative expression of transcription
factors involved in either maintaining B cell identity (PAX5) or
licensing PC differentiation (BLIMP-1, XBP1). We found that
PAX5 was poorly expressed in every PC subset compared to
naive and memory B cells (Figure 1F), whereas BLIMP-1 and
XBP1 were both highly expressed by subsets A, B, and D, but
are nearly undetectable in naive and memory B cells. TheseImmunity 43, 132–145, July 21, 2015 ª2015 Elsevier Inc. 133
A B C D
0
5000
10000
15000
30000
Ig
D
 
CD19 
C
D
13
8 
D 
C 
CD38 
C
D
13
8 
B 
A 
A 
PC subsets 
B 
B A N D C 
IgG 
1K 1K 10K 1K 1K 
1K 1K 10K 1K 1K 
IgA 
C 
!"#$%&'('
P
C
s,
 %
 o
f i
np
ut
 
Ig
G
Ig
A
Ig
G
Ig
A
Ig
G
Ig
A
Ig
G
Ig
A
Ig
G
Ig
A
0
10
20
30 n=6 n=6 
n=6 
n=4 n=6 
A B D C N 
D 
E 
PC subsets 
B A N D C 
A B C D
0.00
0.05
0.10
0.125
0.250
%
 o
f M
N
C
 
C
el
l/m
L 
B
M
 
CD3/CD14 
F 
R
el
at
iv
e 
m
R
N
A 
ex
pr
es
si
on
 
PC subset 
A B C D N M A B C D N M 
PC subset 
A B C D N M 
PC subset 
Xbp-1
0
100
200
300
400
500Pax5
0
20
40
60
80
100 Blimp-1
0
50
100
150
200
250Pax5 Xbp-1 limp-1 
Figure 1. PC Subsets in Human BM
(A) PC subsets in the BM were sorted by excluding cells that express CD3, CD14, and IgD and separating cells into CD19+ and CD19 fractions (top). Lower
panels represent subsets of CD19IgD (left) and CD19+IgD (right) fractions with PC subsets A, B, C, and D identified by CD38 and CD138. (One representative
example of 31 samples analyzed.) Alternative gating strategies quantified similar frequencies of cells in each subset (Figure S1).
(legend continued on next page)
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Figure 2. Characterization of BM PC Sub-
sets and Blood Plasmablasts
Representative histograms of PC subsets A–D and
naive B cells (N) in BM and peripheral blood
(CD138 and CD138+) plasmablasts (PBs) ob-
tained 7 days after vaccination showing surface
expression of CD20, surface Ig, CD27, and HLA-
DR (A), intracellular BLIMP-1 and IRF4 (B), intra-
cellular Ki-67 (C), and surface expression of
CXCR4, CD28, IL-6R, and FcgRIIb (D). Expression
on control naive B cells shown in gray. Represen-
tative number of samples for eachmarker shown in
Table S1.data support the contention that subsets A, B, and D are pri-
marily composed of terminally differentiated PCs.
As B cells differentiate into PCs, they lose features of B cells
(such as CD20 and surface Ig), exit cell cycle, gain expression
of the transcription factor BLIMP-1, and upregulate receptors(B) Number of cells in each PC subset per ml of BM (top) and percent of mononuclear cells from each BM a
(C) Total IgG ELISPOTs (top) and IgA ELISPOTs from subsets A–D and naive B cells (N) from one healthy don
(D) Frequency of IgG- and IgA-secreting cells from subsets A–D and naive B cells by unstimulated sorted cell
subset (p value for subset D was 0.03, for other subsets A, B, C, and N were not significant [NS]). Error bar
(E)Morphology of sorted BMPC subsets (1003magnification) by cytospins andWright-Geimsa stain. Repres
naive B cells are shown. Representative of three separate BM samples. Additional images from one direct b
(F) Quantitative RNA expression of 5,000 sorted cells from subsets A–D and naive (N) and memory (M) B ce
units normalized to GAPDH. One representative example of two experiments.
Immunity 43, 132–for homing and survival in the BM (Hauser
et al., 2002; Tourigny et al., 2002; Turner
et al., 1994). Accordingly, we used multi-
parameter flow cytometry to evaluate
these characteristics (Figure 2; results
summarized in Table S1). As shown in
Figure 2A, CD20 was downregulated on
nearly every cell in all four BM subsets,
consistent with the loss of CD20 that
begins as early as 7 days after vaccination
in newly formed plasmablasts (PBs)
(Qian et al., 2010). In contrast, surface Ig
which is gradually downregulated during
PC maturation was expressed on more
than a third of the cells in subset A, to a
lesser extent in subsets B and C, and on
only 8% of the cells in subset D. This
observation is in contrast to the high fre-
quencies of circulating PBs that express
surface Ig.
Circulating PBs as well as PCs in sub-
sets B and D uniformly expressed high
amounts of CD27, a member of the
TNFR family that is upregulated during B
cell activation and is linked to PC differen-
tiation (Avery et al., 2005), whereas cells
in subsets A and C had a bi-modal distri-
bution of CD27 (Figure 2A). HLA-DR,
a marker of cell activation previously
shown to decrease during PC maturation
(Medina et al., 2002), was expressed bythe vast majority of blood PBs, but exhibited a range of expres-
sion in subset A and was nearly absent from cells in subsets B–D
(Figure 2A).
We also observed nearly universal expression of BLIMP-1 in
subsets A, B, and D, which validates the qPCR results andspirate (bottom). N = 14, bar represents the mean.
or. Input cell numbers are indicated in right corner.
s. Respective number of subjects listed above each
s represent SD.
entative images of 100 cells of each subset A–D and
one marrow aspirate (Figure S2).
lls. Relative mRNA expression is shown in arbitrary
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Figure 3. Identification of LLPCs by ELISPOTs
(A) ELISPOTs of total IgG-secreting cells (top row), tetanus-specific IgG-
secreting cells at steady state (2nd row), tetanus-specific IgG-secreting
cells 21 days after tetanus vaccination (3rd row), measles-specific IgG-
secreting cells (4th row), mumps-specific IgG-secreting cells (5th row), and
influenza (flu)-specific IgG-secreting cells (6th row). Input cell numbers at
right corner.
(B) Frequency of tetanus-specific IgG-secreting cells in subsets A–D and naive
B cells (N) from seven adults (mean age 45, range 33–55 years old) (filled
symbols). Open symbols frequency of tetanus-specific IgG ASCs in subsets
A–D and naive B cells 21 days after tetanus vaccination.
(C) Frequency of measles-specific (closed triangles) or mumps-specific (open
triangles) IgG-secreting cells from BM PC subsets (subsets A, B, C, D), and
naive (N) B cells from 11 adults (mean age 49 years; range 43–70 years). Gray
triangle represents measles IgG PC frequency 1 year afterward.
136 Immunity 43, 132–145, July 21, 2015 ª2015 Elsevier Inc.further suggests that these subsets represent PC lineages (Fig-
ure 2B). In contrast, BLIMP-1 was expressed by only about
half the cells in subset C (Figure 2B). Additionally, we found a
consistently high amount of IRF4 expression in cells from sub-
sets A, B, and D, but observed heterogeneous staining in subset
C (Figure 2B), again suggesting that subset C consists of a
mixture of PCs and non-PCs.
We also found that Ki-67, a nuclear protein associated with
recent cell division, was expressed by a large fraction of cells
in subset A, a lower frequency of cells in subset B, and aminority
of subset D (Figure 2C). In direct contrast, nearly all post-vacci-
nation PBs from peripheral blood expressed Ki-67, consistent
with the idea that these cells were recently generated.
The relative expression of molecules involved in PC homing
and survival was also highly informative (Figure 2D). For
example, CXCR4, a chemokine receptor implicated in PC hom-
ing and retention in the BM (Hauser et al., 2002; Nie et al., 2004),
was expressed on about 70% of cells in subsets A, B, and D, but
on only about 42% of cells in subset C (Figure 2D). CD28, a co-
stimulatory molecule associated with LLPC survival (Rozanski
et al., 2011), was expressed at the highest frequency (20%) on
BM cells in subset D and was virtually absent in blood PB.
Despite the role of IL-6 in PC survival (Hilbert et al., 1995), IL-
6R was mostly expressed by blood PBs and at a much lower fre-
quency by any BM subset (Figure 2D). Finally, the expression of
the inhibitory FcgRIIb, which promotes PC apoptosis (Xiang
et al., 2007), was widely variable from subject to subject but
was typically lower on cells in subsets C and D (Figure 2D).
Together, these results demonstrate that, in contrast to other
BM PC subsets, cells in subset D have a uniform gene expres-
sion pattern that is consistent with the expected features of
LLPCs.
Identification of Human LLPCs in the
CD19–CD38hiCD138+ Subset
Serum antibody responses against vaccination or infection can
last for decades (Amanna et al., 2007), suggesting similar
longevity for LLPCs. To test whether LLPCs were confined to a
discrete population in the BM, we sorted cells from each PC sub-
set from seven healthy adults (mean age 45 years, range 33–55
years) and performed ELISPOTs using plates coated with
tetanus or with anti-IgG to enumerate all IgG-secreting cells
(Lee et al., 2011). We found that tetanus-specific responses
were present in subset D in only four subjects (Figures 3A and
3B), with a mean frequency of 0.51% of total IgG ASCs (range
0%–1.8%). Variability of cell numbers of the PC subsets A, B,
C, and D for each individual was common and thus, to account
for different cell numbers in each well, a Fisher’s exact test
was applied to evaluate the null hypothesis that the frequencies
are equal in the two subsets. Comparisons between subsets A
and D and subsets B and D are shown to be statistically different
(Figure 3B) but there was no statistical difference between sub-
sets C and D due to low cell numbers. Cell recovery from subset(D) Frequency of influenza-specific IgG-secreting cells in subsets A–D and
naive (N) B cells from nine subjects (mean age 45 years, range 30–56 years).
A Fisher’s exact test was then applied: *p < 1 3 102, **p < 1 3 103, ***p <
1 3 104.
Cwas often lowest of all BM subsets due to low frequencies (Fig-
ure 1B) and heterogeneity of this population (not all cells were
PCs; Figure 2B). Thus, we concluded that long-lived responses
reside predominantly in subset D.
To understand the BM PC response after a recent tetanus
vaccination, we enumerated tetanus-specific IgG ELISPOTs af-
ter vaccination on days 0, 7, and 21 in the blood and on day 21
in the BM. We found no tetanus-specific ASCs in the blood prior
to vaccination, but observed 76 ASCs per 106 PBMCs on day 7,
which declined to 0 on day 21. In contrast, we observed tetanus-
specific IgG ELISPOTs on day 21 in the BM in both subsets B
(0.36% of total IgG) and D (0.20% of total IgG) (Figures 3A and
3B), suggesting that these subsets can be rapidly populated
with ASCs after vaccination but that PCs are maintained for
longer periods in subset D.
To conclusively establish the longevity of PCs in subset D, we
obtained BM aspirates from 11 older healthy adults (mean age
49 years; range 43–70 years) with a high serum antibody titer
to either measles or mumps and no history of MMR vaccination
to ensure exposure of these viruses by natural childhood
infection. We sorted cells from each of the PC subsets in the
BM and performed measles-specific and mumps-specific
ELISPOTs. Similar to what we observed with tetanus responses,
measles-specific and mumps-specific ELISPOTs were found
prominently in subset D, with a mean frequency of 0.6% (range
0%–1.8%) of total IgG ASCs (Figures 3A and 3C). Comparisons
between subsets A and D (p value of 8.0943 105) and between
A and B (p value of 3.06 3 1012) were found to be highly signif-
icant. Again, due to low cell numbers, comparison between sub-
sets C and D was not significant. Strikingly, measles-specific
ELISPOT analysis repeated a year later in one subject confirmed
the restriction of the response to subset D, with nearly identical
frequencies (0.6% and 0.5% of total IgG ASCs; Figure 3C).
Although we could not discriminate difference between subsets
D and C due to overall low cell numbers in subsets C, we
conclude that the LLPCs reside in subset D because nearly all
PCs in the BM reside in subsets A, B, and D.
In contrast to measles and mumps, healthy adults typically
encounter influenza virus antigens annually either through vacci-
nation or natural infection. Thus, we postulated that influenza-
specific ASCs, including long-lived PCs elicited by natural in-
fection and recently generated, short-lived PCs, will likely be
distributed between multiple subsets (Skowronski et al., 2008;
Yu et al., 2008). To test this possibility, we sorted PC subsets
from BM aspirates from nine subjects (mean age 45 years, range
30–56 years) and performed influenza-specific ELISPOTs using
the 2010 seasonal vaccine (Halliley et al., 2010; Kyu et al.,
2009). We observed influenza-specific PCs in subsets A, B,
and D (Figures 3A and 3D). Statistical comparisons showed dif-
ferences between subsets A and D and subsets C and D but no
differences between subsets B and D. Together, these results
indicate that short-lived PCs can reside in subset B and possibly
in subset A, whereas LLPCs are restricted to subset D.
Long-Lived Serum Antibody Responses Are Maintained
by CD19–CD38hiCD138+ Cells
Because the half-life of human serum IgG is 15–30 days (Morell
et al., 1970), any measles-specific or mumps-specific circulating
IgG present in adults who have not encountered these antigenssince childhood must be recently produced by LLPCs. To
formally demonstrate the cellular origin of long-lived anti-viral an-
tibodies, we performed a coordinated analysis of serum and
bone marrow of one 64-year-old adult who had been infected
with measles and mumps as a child. Virus-specific IgG was
affinity purified using measles or mumps antigens and interro-
gated by serum Ig proteomic methods described previously
(Cheung et al., 2012; Sato et al., 2012). Virus-specific IgG anti-
bodies were eluted, verified for measles or mumps activity by
antigen-specific ELISA (Figure 4A), then digested and analyzed
on the liquid chromatography-mass spectrometry/mass spec-
trometry (LC-MS/MS) (Figure 4B). Mass spectra identified from
each digested eluate were compared using SEQUEST to
HCDR3 sequence databases (VH1-VH6), generated from cells
in subsets A, B, and D and naive B cells. Top candidate
HCDR3 sequences (VKGGNLLGIRPFDS for measles and AK-
MIGSSAWYPFDY for mumps; Figure 4B) were identified based
on the mapping of high-confidence peptide spectra. A total of
55 (measles) and 67 (mumps) peptides were mapped, covering
100% of the variable region of the gamma chains. Importantly,
the unique measles and mumps HCDR3 peptide sequences
were restricted to RNA sequences present only in subset D
(117 VH sequences containing measles-specific HCDR3 and
59 VH sequences containing mumps-specific HCDR3; Fig-
ure 4C). These virus-specific HCDR3 sequences were not found
in subsets A or B or in naive B cells (Figure 4C).
We also mapped the VL peptides digested from the mumps-
specific Abs and reconstructed the most confident full-length
VL-region sequences (Cheung et al., 2012; Sato et al., 2012).
Using full-length heavy and light chain sequences (HCDR3:
AKMIGSSAWYPFDY and LCDR3: GTWDSSLGIVL), we con-
structed and expressed a recombinant monoclonal antibody
(Cheung et al., 2012; Sato et al., 2012) and tested its specificity
by ELISA. We found that the reconstructed monoclonal antibody
was specific for mumps but did not recognize measles anti-
gens (Figure 4D). Together, these data demonstrate that LLPCs
currently producing serum antibodies specific for antigens
encountered decades previously originate only from subset D
of the human BM.
LLPCs Have a Distinct VH Repertoire that Is Uncoupled
from Other PC Subsets
The antibody repertoires expressed by different PC subsets
were analyzed by NGS of sorted BM populations (subset C
was not included due to low cell numbers). Consistent with our
ELISPOT data (Figure 1C), subset D was differentiated by a pre-
dominant expression of IgG sequences (76%). In contrast, IgG
was lower than IgA in subset A (35% and 65%) and more evenly
split in subset B (56% and 44%). Despite wide variability be-
tween subjects, the average number of somatic mutations was
similar in each of the BM PC subsets (21.6 ± 9.9 in A, 21.8 ±
10.0 in B, and 17.8 ± 9.3 in D).
Repertoire diversity within the different subsets was ascer-
tained using several metrics of clonality. Unique clonotypes
were comprised of all the sequences sharing the same V-D-J re-
arrangement and had a HCDR3 of identical length, with at least
70% sequence similarity within that region and conservation of
the VH-D and D-JH junctional sequences. Of the 5,719 se-
quences obtained from PCs in subset A, we identified 1,037Immunity 43, 132–145, July 21, 2015 ª2015 Elsevier Inc. 137
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Figure 5. Clonal Diversity of BM PC Subsets
and Blood PBs
The VH repertoire for VH families 1–6 was deter-
mined by next generation sequencing of cells in (A)
BM subsets A, B, and D and (B) CD138+ and
CD138 PBs in peripheral blood after tetanus
vaccination. The cumulative percentage of se-
quences (y axis) versus lineage (clonal) size (x axis)
ranked by abundance. D50 designates the number
of clonotypes in the top 50% of the sequences and
D80 represents the number of clonotypes in the top
80% of the sequences. Numbers above each plot
indicate frequency of unique IgG clonotypes per
total number of IgG sequences.clonotypes; of the 9,411 sequences from subset B, we identified
3,319 clonotypes; and of the 13,811 sequences from subset D,
we identified 2,578 clonotypes (Figure 5A). We also found that
PCs in all three subsets expressed a very diverse repertoire
that was primarily composed of singletons and clonotypes of
relatively small size. Specifically, the most abundant clonotype
in each subset made up only 1.5% of total sequences in subset
A, 2.2% in B, and 1.6% in D. A high degree of diversity within all
the BM PC subsets was also indicated by very high D50 and D80
scores (representing the number of clonotypes accounting for
the top 50% or 80%, respectively) of sequences within a given
population. Thus, the D50 scores for subsets A, B, and D were
156, 488, and 299, respectively, and the D80 scores were 424,
1,545, and 978, respectively (Figure 5A).
As a comparative counterpoint of oligoclonal PB populations
(Qian et al., 2010; Wrammert et al., 2008), we analyzed
CD138+ and CD138 PBs sorted from healthy subjects 7 days
after tetanus vaccination and sequenced the productively rear-
ranged VH genes from cells that had switched to either IgG or
IgA. Sequences from CD138 PBs were comprised of 57%
IgG and 43% IgA, whereas sequences from CD138+ PBs were
comprised of 63% IgG and 37% IgA. Of the 10,735 sequences
from CD138 PBs, we identified 459 clonotypes, and of the
11,892 sequences from CD138+ PBs, we identified 486 clono-
types (Figure 5B). The most abundant single clonotype in
CD138 PBs made up nearly 30% of the total sequences (Fig-
ure 5B), whereas the most frequent clonotype in the CD138+
PBs made up nearly 14% of the total sequences. Moreover,
the D50 scores of CD138 and CD138+ PBs were 2 and 4,
respectively, whereas the D80 scores of CD138 and CD138+
PBs were 10 and 25, respectively (Figure 5B). Thus, unlike the
PCs in the BM, the acutely circulating PB subsets are dominated
by a very small number of substantially expanded clones.Figure 4. Serum Antibodies to Measles and Mumps Restricted to BM
(A) ELISA activity of affinity-purifiedmeasles-specific andmumps-specific serum a
(red), and mumps eluted fraction (black) are shown.
(B) LC-MS/MS spectra produced and matched by SEQUEST to the full V-reg
MIGSSAWYPFDYWGQGTLVAVSSASTK (for mumps) contain heavy chain CDR3
(C) Number of HCDR3 sequences identified from a total of 24,003 gamma chain se
B cells that match the peptide sequences obtained in (B).
(D) Specificity of recombinant monoclonal antibody reconstituted from the VH an
tryptic peptides HCDR3 AKMIGSSAWYPFDY and LCDR3 GTWDSSLGIVL from
original serum are shown as controls.A separate LLPC compartment that contains unique antibody
responses would be expected to express a repertoire that is
distinct from other PC populations. Thus, we determined the de-
gree of inter-relatedness of the PCs in subsets A, B, and D. As
illustrated by Circos plots (Figures 6A and 6B) for IgG and IgA se-
quences, a large fraction of subset Dwas indeed uncoupled from
other BM populations. However, subset D shared 6% of IgG and
11%of IgA clonotypes with subset A and 15%of IgG and 16%of
IgA with subset B (Figures 6A and 6B). Thus, a relatively small
segment of subset D sequences was shared with subsets A
and B. In contrast, the repertoires of post-vaccination blood
CD138+ and CD138 PBs were highly connected, as shown by
the fact that they shared 58% and 41% of IgG and IgA se-
quences, respectively (Figures 6C and 6D).
Given the polyclonality of subset D and in order to correct for
sampling efficiency, we performed a control experiment by split-
ting 20,000 cells sorted from subset D into two fractions of
10,000 cells each and sequencing them in separate reactions.
We found that only 44% of all sequences and 40% of the line-
ages were concordant between the two theoretically identical
populations, a result consistent with a very polyclonal compart-
ment and small average clone sizes. After applying a correction
factor generated from these data, we conclude that the cor-
rected level of repertoire connectivity between subsets D and
A is 13% for IgG and 25% for IgA, and the corrected level of
repertoire connectivity between subsets D and B is 34% for
IgG and 36% for IgA. This result is in sharp contrast with the de-
gree of connectivity between subsets A and B (43% of IgG and
30% of IgA prior to correction). Therefore, the application of
the same correction factor would indicate almost complete iden-
tity between subsets A and B. Correction factors are at best es-
timates to distinguish polyclonal versus oligoclonal repertoires.
In all, PC subsets in the BM are highly polyclonal with subset DSubset D
ntibodies from a 64-year-old adult. Original sera (blue), measles eluted fraction
ion tryptic peptide GGNLLGIRPFDSWGQGTLVTVSSASTK (for measles) and
(underlined) and their junction with the framework-4.
quences from subset A, 90,061 from B, 158,114 fromD, and 28,351 from naive
d VL sequences from the BM subset D NGS data that aligned with VH and VL
the mump-eluted fractions. Total anti-measles and mumps activities from the
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Figure 6. Connectivity of VH Repertoires of
PC Subsets in the BM
Connectivity is shown with circos plots for (A) IgG
and (B) IgA sequences for PC subsets A, B, and D
in the BM of a 40-year-old adult at steady state.
Connectivity is indicated for (C) IgG and (D) IgA
sequences from CD138+ and CD138 PB subsets
in peripheral blood 7 days after tetanus vaccination
(age 56 years old). The red line in the outer ring
denotes the average number of mutations for each
population and the gray trace represents the
number of mutations found in each clone. The
second track indicates the numbers of individual
sequences. The divisions in the third track identify
separate clonal populations. Clonal relationships
are indicated by gray or colored lines and the
thickness of the lines represents the number of
clones related between populations. Colored lines
in the middle represent relationships between
clonotypes that consist of more than 50 se-
quences, and the gray lines denote relationships of
clonotypes of fewer than 50 sequences. Boxes
below show percent of sequences or clonotypes
that are connected between the indicated PC/PB
subsets in the BM or blood.including a largely independent segment, whereas recently
expanded peripheral PBs after acute antigen exposure are highly
inter-related and are primarily comprised of a limited number of
expanded clones.
Subset D Has a Distinct RNA Transcriptome with Genes
Involved in Autophagy
To further understand the properties andmechanisms of survival
of subset D as the LLPC compartment, we performed RNA
sequencing in BM subsets A, B, and D at steady state in five
separate healthy adults (mean ages 44 ± 12 years, 25 to 54
years). (Subset C was not collected due to variable BLIMP-1
staining or low numbers.) Gene expression was log-transformed
and selected based on pairwise comparisons from 20,692 avail-
able genes for false discovery rate (FDR) < 0.00001 and absolute
value of fold change >1.5. In the BM, 74, 768, and 154 genes
were differentially expressed between subsets A and B, A and
D, and B and D, respectively (Figures 7A and 7B). Initial IPA ca-
nonical pathway analysis identified several pathways important
for BM survival including CD28 and mTOR signaling.
PCA analysis showed that subset D clearly segregated from
subsets A and B following a pattern of sequential differentiation
progressing from subset A to B to D along PC1 (Figure 7C). Of140 Immunity 43, 132–145, July 21, 2015 ª2015 Elsevier Inc.significant interest, genes involved in acti-
vation of autophagy, a process shown to
be critical for the survival and function of
mouse PCs (Pengo et al., 2013), were a
major contributor to PCA separation of
subset D relative to the other BM PC pop-
ulations (differentially expressed genes
involved in autophagy are listed in
Figure S3).
To further explore autophagy activa-
tion, we performed LC3BII staining byconfocal microscopy and enumerated autophagosomes by
electron microscopy (EM). Punctate LC3BII is a well-established
marker of activated autophagy resulting from conversion of the
autophagy factor LC3BI (ATG8) to its phosphatidylethanol-
amine-conjugated form LC3BII, leading to its association with
the autophagosome membrane. Punctuate LC3BII expression
is unique to subset D (Figure 7D). In addition, EM also showed
a higher frequency of autophagosomes in subset D (85% of all
subset D PCs) compared to 50% in subset A or 55% in subset
B PCs (Figures 7E and 7F). Combined, transcriptome analysis
and microscopy results indicate that activated autophagy is a
distinctive feature of subset D and identify this pathway as an
important mechanism of survival of human LLPCs.
DISCUSSION
Acute recall immune responses generate short-lived proliferative
plasmablasts that produce a transient burst of antigen-specific
antibodies. Thereafter, pathogen-specific antibodies are sus-
tained by resting, terminally differentiated PCs that in mouse
models might survive for the life of the animal. Similarly, LLPCs
have been proposed in humans to explain the persistence, in
the absence of antigen-specific stimulation, of anti-microbial
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Figure 7. Transcriptome Analysis of PC Subsets and Upregulation of Autophagy Pathways
(A) Numbers of selected genes are shown from five BMaspirates sorted for subsets A, B, and D. Geneswere selected based on pairwise comparisons from a total
of 20,692 available genes. False discovery rates (FDR) were computed from p values as described by Storey (2002). Heat map shows per-gene z-score
of log10-transformed, replicate-averaged data (zeros set to non-zero minimum of profiles). The selection criteria for a pairwise comparison were as follows:
FDR < 0.00001, absolute value of fold change > 1.5, and the maximum group mean > 0.5 (roughly equivalent to non-log expression of 0.3).
(B) Numbers of genes differentially expressed between subsets A and B, A and D, and B andD. Directionality corresponds to the first group relative to the second.
For example, ‘‘Up’’ in A versus B means A > B.
(C) Principal-component analysis for subsets A, B, and D based on 788 selected genes.
(D) LC3BII staining of subsets B and D by confocal microscopy.
(E) Electron microscopy of subsets A, B, and D. Red arrow shows lipid droplets, green arrows show autophagosomes (APs).
(F) Percentage of AP in BM PC subsets by EM (number of cells with APs/total cells) subset A: 11/22, subset B: 34/62, and subset D: 47/55.
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antibodieswith very longhalf-lives (10 to>3,000 years). However,
direct proof for this mechanism and the actual identity of human
LLPCs have remained elusive (Gonza´lez-Garcı´a et al., 2006,
2008; Hargreaves et al., 2001; Liu et al., 2012; Mei et al., 2015;
Odendahl et al., 2005; Qian et al., 2010; Radbruch et al., 2006),
and alternative models, most notably the polyclonal bystander
stimulation ofmemory cells, have beenproposed to explain sero-
logicalmemory (Bernasconi et al., 2002). Thesecritical gaps stem
from the inability to determine the longevity of multiple PC sub-
sets previously reported in the human BM and to ascribe the
generation of long-lived antibodies to any singular population.
Instead, location in the bone marrow, a resting state, and the
expression of markers associated with ASC maturation (such
as expression of CD138 and downregulation of HLA-DR or
CD19) are frequently used as surrogate markers for LLPCs.
Here we identified in the human BM a population of CD19
CD38hiCD138+ cells (subset D) that unambiguously contains
LLPCs. These cells have a distinctive morphology, express
BLIMP-1, IRF4, and XBP-1, and are non-cycling. Critically, as
determined by ELISPOT, subset D is the only population of cells
to secrete antibodies specific for measles and mumps viruses
more than 40 years after infection. Such a definitive link was
demonstrated by exclusive matching of the serum anti-viral anti-
body proteome and the BCR repertoire expressed by subset D
but not by any other BM PC compartment. These findings are
validated by the demonstration that recombinant antibodies re-
constructed from subset D sequences recapitulate the anti-viral
specificity of the serum antibody fraction specific for the corre-
sponding virus.
In contrast to subset D, other BM PC subsets produce anti-
bodies against more recent antigens, such as influenza and
tetanus, but not measles or mumps, thereby suggesting that
they are relatively short-lived. Although these subsets share
PC features, such as low expression of PAX5 and CD20 and
high expression of BLIMP-1, XBP-1, and IRF4, other character-
istics were indicative of a more short-lived phenotype. Thus,
consistent with recent differentiation from B cells, significant
fractions of subsets A–C retained sIg and MHC class II and ex-
pressed lower levels of CD27. Similarly, substantial Ki-67
expression in subsets A–C is in keeping with recent derivation
from proliferating precursors.
The longevity of measles- and mumps-specific antibody re-
sponses is attributed to the intrinsic lifespans of LLPCs gener-
ated after viral infection. However, despite being generated by
vaccination, the half-life of the tetanus-specific antibody res-
ponse is remarkably long at 11 years (Amanna et al., 2007),
compared to the much shorter half-life of antibody responses
to polysaccharides (Kelly et al., 2006). Thus, it is perhaps not sur-
prising that, under steady-state conditions, we find tetanus-spe-
cific PCs in the LLPC compartment. Nevertheless, the faster
decay of anti-tetanus responses relative to anti-measles and
-mumps responses demonstrates significant variability in the
lifespan of LLPCs generated under different conditions.
Antibody responses to influenza vaccination also decline rela-
tively quickly, although detectable serum titers can persist for 90
years (Yu et al., 2008), suggesting that both short-lived and long-
lived PCs are generated. Consistent with this idea, we find influ-
enza-specific PCs in subsets A and B as well as in subset D.
Given that the influenza virus is constantly changing by yearly142 Immunity 43, 132–145, July 21, 2015 ª2015 Elsevier Inc.antigenic drift and the occasional shift in subtype (Palese and
Shaw, 2007), it could be predicted that influenza-specific PCs
in subset D will produce antibodies against temporally distant
serotypes, whereas cells in subsets A, B, and even D will contain
cells reactive withmore contemporary serotypes. In addition, the
presence of anti-influenza antibodies in LLPCs could represent
responses to the conserved nucleoprotein antigens shared be-
tween influenza strains encountered decades apart (Kaminski
and Lee, 2011). Differentiating between these possibilities will
require comprehensive studies of the fine specificity of anti-influ-
enza PCs.
LLPCs could derive fromB cell precursors shared by other BM
PC subsets through a progressive differentiation process in
which phenotypic changes in the different PC subsets would
reflect the age of the cells in each population, with the oldest
cells progressively losing CD19 and surface Ig. This sequential
differentiation model is supported by the progressive transcrip-
tional separation of the different PC populations demonstrated
by PCA, which would be consistent with sequential maturation
of subset D from common precursors differentiating through
stages A and B.
Alternatively, LLPCs could originate from separate precursors
that would activate specific differentiation, homing, and/or sur-
vival programs that ultimately determine their longevity upon tak-
ing residence in the bonemarrowmicroenvironment. Our current
data cannot definitively distinguish between these models.
Extended longitudinal studies after primary immunization with
neoantigens will be required to clarify the ontogeny of human
LLPCs.
Nevertheless, human LLPCs are distinguished from other BM
PCs, including other CD138+ cells, by several unique features
that provide important mechanistic insights regarding their dif-
ferentiation and survival programs. Thus, subset D cells include
prominent cytoplasmic vacuoles representative of ongoing lyso-
somal autophagy, a process recently recognized as critical for
PC homeostasis by regulating Ig secretion and optimizing en-
ergy metabolism and survival (Pengo et al., 2013). In keeping
with this concept, the combination of transcriptional programs
and microscopy analysis strongly point to active autophagy as
a major mechanism of LLPC survival.
This study contributes the first high-throughput sequencing
analysis of human BM PCs. NGS is a powerful means of testing
the expected properties of a separate LLPCs. A central predic-
tion for a distinct LLPC compartment is that, over a lifetime, it
would progressively accumulate cells that have responded to a
myriad of antigens. A corollary of this prediction is that in adults,
a well-established LLPCwould display a highly diversified reper-
toire, a property that is consistent with our results. Interestingly,
repertoire analysis established the presence of two distinct com-
ponents in subset D. We postulate that the larger component,
which is uncoupled from other BM PC populations, represents
steady-state LLPCs containing the historical record of B cell re-
sponses, a conclusion supported by the exclusive presence of
mumps- and measles-specific PCs in subset D decades after
antigen exposure. In contrast, a much smaller fraction of subset
D is clonally connected with subsets A and B, a feature we inter-
pret as indicative of new arrivals derived from more recent B cell
responses. Newcomers into the D subset might eventually
become bona fide LLPCs and contribute to the steady-state
fraction depending on their intrinsic longevity (Amanna and
Slifka, 2010) and/or their ability to compete for survival niches.
This model would also account for the presence of some Ki-
67+ cells in subset D, because these cells can be derived from
recently dividing precursors (Cassese et al., 2003; Radbruch
et al., 2006). Alternatively, the presence of a low frequency of
Ki-67+ cells in subset D could indicate that limited homeostatic
proliferation might be important to maintain the LLPC pool, as
shown for human memory cells (Macallan et al., 2005).
In summary, the identification of CD19CD38hiCD138+ cells in
human BM as a bona fide LLPC compartment will enable inves-
tigators to understand the cellular source of different types of
protective and pathogenic antibodies. It will also pave the way
for a precise understanding of the molecular roadmaps underly-
ing the differentiation and survival of this critical compartment. In
turn, this knowledge will be central to our ability to maximize the
generation of long-lived protective responses in microbial vacci-
nation and prevent the accumulation of pathogenic PCs in auto-
immune diseases and transplantation.
EXPERIMENTAL PROCEDURES
Subjects
Bone marrow aspirates were obtained from 35 healthy adults (age 22–70
years, mean 44 ± 13). Eleven of these subjects were older (age >40 years,
range 43 to 70, mean 52 ± 8 years) and were recruited due to high serum titers
of measles or mumps from history of natural infection with measles and
mumps viruses during childhood. All adult subjects were vaccinated to influ-
enza vaccination 1–11 months prior to BM aspirates. Blood and bone marrow
aspirate was obtained from each patient and mononuclear cells were isolated
by density gradient centrifugation. Blood for serum and BMwere also obtained
from one 64-year-old man for proteomics studies. For vaccinated and healthy
asymptomatic adults, two healthy adult subjects (ages 27 and 56 years) were
enrolled. Subjects received the tetanus toxoid vaccinations Td or combination
Tdap as a part of routine medical care. PBMCs were isolated pre-vaccine and
on days 6–7 for all vaccination subjects. All subjects in this study were re-
cruited at the University of Rochester Medical Center or Emory University,
and all studies were approved by the Institutional Review Boards at the Univer-
sity of Rochester Medical Center and Emory University.
VH Next-Generational Sequencing
Total cellular RNA was isolated from blood CD19+CD138+ and CD19+CD138
PBs after tetanus vaccination BM PC subsets A, B, and D from three BM using
theRNeasyMini Kit (QIAGEN) by following themanufacturer’s protocol. Approx-
imately 400 pg of RNAwas subjected to reverse transcription with the iScript RT
kit (BioRad). Resulting cDNA products were includedwith 50 nMVH1-VH6-spe-
cific primers and 250 nM Ca-, Cm-, and Cg-specific primers in a 20 ml PCR
reaction using High Fidelity Platinum PCR Supermix (Life Technologies) and
amplified by 40 cycles. Nextera indices were added and products were
sequenced on an Illumina MiSeq with a depth of approximately 300,000 se-
quences per sample. One BM sample was used as a control, 20,000 subset
D cellswere collected, RNAwas isolated, andNGSwasperformedas described
above. All sequences were aligned with IMGT.org/HighVquest (Alamyar et al.,
2012). Sequences were then analyzed for V region mutations and clonality. All
clonal assignments were based on matching V and J regions, matching CDR3
length, and 70%CDR3 homology. All sequences are plotted with Matlab or Cir-
cos visualization tools (Krzywinski et al., 2009).
Serum Proteomics
Measles- or mumps-specific polyclonal antibodies from one adult (age 64
years) were purified by affinity chromatography using a custom column con-
sisting of measles or mumps antigens and fractions were eluted, verified for
measles or mumps activity, then digested with chymotrypsin, pepsin, elas-
tase, and trypsin and analyzed by the LC-MS/MS. MS/MS spectra were
searched with SEQUEST against the V-region full peptides generated fromthe sequences provided by the NGS results of subsets A, B, and D and naive
B cells. Top candidate V-region sequences including CDR3 peptides from
measles and mumps antibodies were identified as previously described
(Cheung et al., 2012; Sato et al., 2012).
Monoclonal Mumps-Specific Antibody Reconstruction
The top candidate gamma and kappa chains, containing HCDR3 AKMIGSSA
WYPFDY and LCDR3 GTWDSSLGIVL, identified in subset D from the affinity-
purified mumps-specific antibodies through the use of proteomics, were
synthesized, cloned, and expressed in 293T cells. Specificity of the mono-
clonal antibody was tested by ELISA against measles and mumps antigens.
ACCESSION NUMBERS
The accession number for the NGS VH repertoire and RNA transcriptome da-
taset reported in this paper is SRA: SRP057017.
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